{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Yu H"],"funding":["Innovative Research Team of Science and Technology in Yunnan Province","Major Program on Basic Research Projects of Yunnan Province","the National Genetically Modified Organisms Breeding Major Projects","Innovative Research Team (in Science and Technology) in University of Yunnan Province","the National Natural Science Foundation of China"],"pagination":["41"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5828148"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["16(1)"],"pubmed_abstract":["Background
Laron syndrome is an autosomal disease resulting from mutations in the growth hormone receptor (GHR) gene. The only therapeutic treatment for Laron syndrome is recombinant insulin-like growth factor I (IGF-I), which has been shown to have various side effects. The improved Laron syndrome models are important for better understanding the pathogenesis of the disease and developing corresponding therapeutics. Pigs have become attractive biomedical models for human condition due to similarities in anatomy, physiology, and metabolism relative to humans, which could serve as an appropriate model for Laron syndrome.Methods
To further improve the GHR knockout (GHRKO) efficiency and explore the feasibility of precise DNA deletion at targeted sites, the dual-sgRNAs/Cas9 sy"],"journal":["Journal of translational medicine"],"pubmed_title":["Generation of GHR-modified pigs as Laron syndrome models via a dual-sgRNAs/Cas9 system and somatic cell nuclear transfer."],"pmcid":["PMC5828148"],"funding_grant_id":["31560637","2014FC006","2016ZX08009-003-006"],"pubmed_authors":["Xu K","Li H","Pan W","Jia B","Zhao HY","Yu H","Wei HJ","Long W","Guo J","Zhang X","Huang X","Qing Y","Zhao H"],"additional_accession":[]},"is_claimable":false,"name":"Generation of GHR-modified pigs as Laron syndrome models via a dual-sgRNAs/Cas9 system and somatic cell nuclear transfer.","description":"Background
Laron syndrome is an autosomal disease resulting from mutations in the growth hormone receptor (GHR) gene. The only therapeutic treatment for Laron syndrome is recombinant insulin-like growth factor I (IGF-I), which has been shown to have various side effects. The improved Laron syndrome models are important for better understanding the pathogenesis of the disease and developing corresponding therapeutics. Pigs have become attractive biomedical models for human condition due to similarities in anatomy, physiology, and metabolism relative to humans, which could serve as an appropriate model for Laron syndrome.Methods
To further improve the GHR knockout (GHRKO) efficiency and explore the feasibility of precise DNA deletion at targeted sites, the dual-sgRNAs/Cas9 sy","dates":{"release":"2018-01-01T00:00:00Z","publication":"2018 Feb","modification":"2025-04-21T20:16:11.622Z","creation":"2019-03-26T23:04:27Z"},"accession":"S-EPMC5828148","cross_references":{"pubmed":["29482569"],"doi":["10.1186/s12967-018-1409-7"]}}